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Abstract. To determine the association between a range of inherited blood disorders and indicators of poor nutrition,
we analyzed data from a population-based, cross-sectional survey of 882 children 6–35 months of age in western Kenya. Of
children with valid measurements, 71.7% were anemic (hemoglobin < 11 g/dL), 19.1% had ferritin levels < 12 mg/L, and
30.9% had retinol binding protein (RBP) levels < 0.7 mmol/L. Unadjusted analyses showed that compared with normal
children, homozygous a+thalassemia individuals had a higher prevalence of anemia (82.3% versus 66.8%, P = 0.001), but a
lower prevalence of low RBP (20.5% versus 31.4%, P = 0.024). In multivariable analysis, homozygous a+-thalassemia
remained associated with anemia (adjusted odds ratio [aOR] = 1.8, P = 0.004) but not with low RBP (aOR = 0.6, P = 0.065).
Among young Kenyan children, a+-thalassemia is associated with anemia, whereas G6PD deficiency, haptoglobin 2-2, and
HbS are not; none of these blood disorders are associated with iron deficiency, vitamin A deficiency, or poor growth.
INTRODUCTION
A high percentage of young children in Kenya have
inherited blood disorders. Among the most common in this
region are a+-thalassemia, sickle cell hemoglobin (HbS),
glucose-6-phosphate dehydrogenase (G6PD) deficiency, and
haptoglobin (Hp) 2-2. A high prevalence of all of these disorders
have been shown previously in Kenya and elsewhere in sub-
Saharan Africa, with heterozygous a+-thalassemia (−a/aa) and
homozygous (−a/−a) a+-thalassemia estimated at 39% and
15%, respectively, in coastal Kilifi,1 sickle cell trait (HbAS)
prevalence estimated at 15–28%,2,3 G6PD deficiency estimated
as high as 20%,4 and Hp 2-2 estimated as high as 25%.5,6
All four blood disorders are associated with adverse health
outcomes with varying severity and potential effect on nutri-
tion status. Individuals with a+-thalassemia are largely asymp-
tomatic, but experience chronic mild anemia.7 HbAS is
generally regarded as a benign condition, whereas sickle cell
anemia (HbSS) is associated with chronic ill health and
reduced life expectancy.8 Individuals with G6PD deficiency
are more susceptible to hemolytic anemia triggered by certain
drugs or foods.4 Inheritance of the Hp 2-2 genotype is not a
blood disorder per se, but because the protein is active in iron
metabolism, it may have a role in anemia.9,10
The relationships between these four blood disorders and
risk for anemia and malaria are multifaceted and have the
potential to confound the interpretation of nutrition indicator
outcomes if not taken into consideration. On one hand they
may modify the risk of anemia and chronic malnutrition
through reduced risk of severe malaria;11,12,13 on the other
hand some inherited blood disorders (including a+-thalassemia
and HbSS) can have a negative impact on hemoglobin con-
centration and subsequent growth.11,14 For example, studies
have linked HbSS with growth retardation and an increase in
macronutrient requirements,15,16 whereas the prevalence of
stunting was reported to be lower among young HbAS children
who experienced malaria episodes in Ghana than among
HbAA children.13 Despite the potential for direct and indirect
effects of anemia and malaria infection on growth and nutri-
tion indicators, the relationships between inherited blood dis-
orders and the overall nutritional status of young children are
not well known. The confounding effects of inherited blood
disorders are rarely considered in studies of nutrition in areas
where inherited blood disorders are widespread.
Considering the high prevalence of blood disorders in sub-
Saharan Africa, information about the relationship between
them and children’s risk for anemia, iron deficiency, vitamin
A deficiency (VAD), and poor growth (stunting, underweight,
wasting) can be useful for interpreting the results of nutrition
surveys and monitoring the results of nutrition interventions.
Our purpose in this study was to investigate the relationship
between each of four inherited blood disorders (Hp 2-2,
G6PD deficiency, HbAS/HbSS, and the a+-thalassemia geno-
types [−a/aa,−a/−a]) and the prevalence of six conditions
associated with poor nutrition (anemia, iron deficiency,
VAD, stunting, wasting, and underweight) among preschool
children in western Kenya.
METHODS
Study setting and design. We used data from a population-
based, cross-sectional survey of children who participated in
the Nyando Integrated Child Health and Education Project
(NICHE), a cluster randomized trial that evaluated the effec-
tiveness of the promotion and sale of health products, including
micronutrient powders, in 60 study villages during 2007–2010.
A complete description of NICHE, including the study sam-
pling methodology and results, are provided elsewhere.17–20
In brief, the survey was conducted in rural Nyando Division
in Nyanza Province, western Kenya, where the population is
of the Luo ethno-linguistic group and where the main occupa-
tion is subsistence farming; previously collected data from the
NICHE project indicated a high rate of morbidity from
malaria and poor nutrition among residents of this area.20
In 2007, researchers used the 1999 Nyando District census as
a reference to select 30 intervention villages and 30 compari-
son villages for participation in the survey, with the probabil-
ity of a village’s selection proportional to its size. An updated
household census was conducted before the August 2010
survey, and 19 compounds per village were randomly selected.
All children 6–35 months of age from each compound were
eligible for inclusion in the survey. Of 1,079 age-eligible
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children, we included 861 in our analyses of survey data
(Figure 1); however, because of inadequate blood samples
from some children, we did not include all 861 in all analyses.
Field staff used birth certificates or immunization records to
verify the ages of all children in the survey.
Assessment of children’s nutritional status, hemoglobin
genotype, and socioeconomic status. Field workers adminis-
tered a questionnaire to a parent or other primary caretaker
of participating children to collect information on the chil-
dren’s age, sex, illness status, and use of micronutrient supple-
mentation. The questionnaire was written in English, translated
into the local Dholuo language, and back-translated into
English to verify the accuracy of the original translation.
Caretakers were asked to report whether children had experi-
enced diarrhea, respiratory disease, or fever within the pre-
ceding 24 hours, and clinical malaria was diagnosed on the
basis of a positive malaria blood smear in conjunction with
a report of fever in the preceding 24 hours. The survey also
collected data on multiple indicators of socioeconomic
status (SES), including maternal education, household assets,
and infrastructure.
Trained anthropometrists measured the recumbent length
of children < 24 months of age and the standing height of
those ³ 24 months of age to the nearest 0.1 cm using a wooden
measuring board (Irwin Shorr Productions, Olney, MD) and
measured children’s weight to the nearest 0.1 kg using a digi-
tal scale (Seca Corp., Hanover, MD). We defined stunting,
underweight, and wasting as, respectively, a height-for-age
z-score (HAZ), a weight-for-age z-score (WAZ), and
a weight-for-height z-score (WHZ) less than two standard
deviations below the mean values for these scores based on
international growth standard data.21
Capillary blood was used for all hematological analyses.
After wiping the first drop of blood, field workers measured
the hemoglobin (Hb) concentration in the second drop using
a HemoCue B-Hemoglobin device (A¨ngelholm, Sweden),
collected 400–500 mL of blood in heparinized microcontainers,
and made Giemsa-stained thick blood films. Microcontainers
of collected blood were stored in cold boxes during the day
until centrifugation each evening.
Anemia was defined as an Hb concentration < 11.0 g/dL;22
because all study villages were at elevations below 1,000 m,
we did not apply an altitude correction. Collected blood sam-
ples were analyzed at the Kenyan Medical Research Institute
(KEMRI)/Centers for Disease Control and Prevention (CDC)
laboratory in Kisian, Kenya to determine whether malaria
parasitemia were present and, if so, in what quantity. Children
with severe anemia (Hb levels < 7.0 g/dL) or clinically diag-
nosed malaria were referred to the nearest hospital or clinic
for follow-up. Ferritin, C-reactive protein (CRP), transferrin
receptor (TfR), a-1-acid glycoprotein (AGP), and retinol
binding protein (RBP) were analyzed using a sandwich
enzyme-linked immunosorbent assay (ELISA) technique
(VitA-Iron Laboratory, Germany).23 Low ferritin was defined
as a plasma ferritin concentration < 12 mg/L,24,25 and iron
deficiency was defined as low ferritin in the absence of inflam-
mation (a CRP level £ 5 mg/L and an AGP level £ 1 g/L).26
Although TfR data were collected, we did not include it
in this analysis because of the potential effect of malaria,
inflammation, and hemoglobinopathies on TfR levels.27 We
defined low RBP as < 0.7 mmol/L28 and VAD as low RBP
with no inflammation.
b-globin genotyping for the HbA and HbS alleles and
the 3.7-kilobase a-globin chain deletion (the most common
African form of a+-thalassemia) and the Hp genotypes were
determined by polymerase chain reaction (PCR) as described
in detail previously.10,29–31 On the basis of results from recent
phenotypic studies (Shivang Shah, unpublished data), we clas-
sified males as G6PD-deficient if they were hemizygous for
the G6PDA− allele and females as G6PD-deficient if they
were either homozygous for the G6PDA− allele or heterozy-
gous for both the G6PDA− and G6PDA alleles.29,32 All genetic
analyses were conducted at the KEMRI-Wellcome Trust
laboratory in Kilifi, Kenya; details of all analyses are
available elsewhere.17,30,31
Iron supplementation and Sprinkles (a micronutrient
powder) use were also assessed in the survey. The Sprinkles
formulation used in this area included 14 micronutrients,
including 12.5 mg of iron as microencapsulated ferrous fuma-
rate and 375 mg of vitamin A.33 SES was categorized in
Figure 1. Selection of survey participants in Nyando Division, Kenya.
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quintiles to relative poverty using a principal components
analysis (PCA) wealth index developed by the World Bank.34
Data synthesis. In our analyses, we categorized children
into two age groups: 6–23 months and 24–35 months to cap-
ture those within the critical nutrition period of < 24 months
compared with those 24 months and over.35 The Hb, ferritin,
and RBP levels were dichotomized using the cut-off points
defined previously because the primary objective was to
identify whether nutritional status at internationally accepted
definitions varied by blood disorder. Because only 30 children
were classified as wasted, we did not include wasting as a
covariate in logistic regression.
Statistical analysis.We used the Rao-Scott c2 test36 to iden-
tify crude associations between the blood disorders (primary
exposure) and other variables. We then used logistic regres-
sion analysis to assess the relationship between each blood
disorder and any nutrition outcome (anemia, low ferritin,
low RBP, stunting, wasting, and underweight) shown to be
statistically significant (c2 P < 0.05). The HbAA children
served as the reference for those with HbAS, normal (aa/aa)
genotype or heterozygote (−a/aa) children for a+-thalassemia
homozygote children (−a/−a); children with normal G6PD
levels for those with G6PD deficiency, and children with the
Hp 1-1/Hp 2-1 genotype served as the reference group in
analyses for Hp 2-2. Because only 14 children carried the
HbSS genotype, we did not include these children in the logis-
tic regression analysis.
In multivariable models, acute and chronic inflammation
were accounted for by controlling for both CRP and AGP in
the adjusted model.26 We also assessed for interaction and
confounding of covariates identified in previous studies,
including male sex, low SES (defined as the bottom three
PCA quintiles), illness (diarrhea, respiratory illness, or fever)
within the preceding 24 hours, child-feeding practices in the
preceding 24 hours (breastfeeding, tea consumption, iron sup-
plementation, use of Sprinkles, dirt/earth consumption [a form
of pica behavior]), inflammation (elevated CRP and/or AGP),
and malaria status. To account for co-inheritance of blood
disorders and co-existing health conditions, we also included
nutrition outcomes and blood disorders as covariates in initial
models. Blood disorders were retained in final models regard-
less of P value.
We included covariates in our full logistic regression model
if results of our bivariate analysis indicated there was a signif-
icant association with a blood disorder (P < 0.05), if the inter-
action between the primary exposure and covariate was
significant (P < 0.05), or if they changed the odds ratio (OR)
for the relationship between the primary exposure and the
covariate by more than 10%. We conducted backward regres-
sion first for any interaction terms and then by removing
variables that were not confounders or independent predic-
tors of the outcome. At each step, we monitored the OR for
the relationship between the primary exposure and the covar-
iate to ensure that removal of a covariate did not result in
confounding. However, we kept age, sex, and all other blood
disorders in the model as potential confounding covariates
regardless of the P value for their relationship with a blood
disorder of interest. We used the same process for all signifi-
cant associations between blood disorders and indicators of
poor nutrition. We defined collinearity between covariates as
condition indices (CI) > 30 using a SAS colinearity macro37 in
the final models. Final models included all remaining signifi-
cant two-way interactions, statistically significant independent
variables, and confounding variables as defined above.
Data were analyzed using SAS version 9.3 (SAS Institute
Inc., Cary, NC) taking into account the complex survey design
of 60 primary sampling units (villages) by using PROC
SURVEYFREQ and PROC SURVEYLOGISTIC. We con-
sidered results to be statistically significant if two-sided
P values were < 0.05.
Ethical considerations. The Scientific Steering Committee
and the Ethical Review Committee of KEMRI in Nairobi
and the CDC Institutional Review Board approved all
study protocols.
RESULTS
We classified 29.8% of children surveyed as stunted, 12.1%
as underweight, 3.5% as wasted, 19.1% as having low ferritin
levels, and 30.9% as having low RBP levels (Table 1). We
classified 59.4% as having one or more of the following geno-
types or conditions:Hp 2-2, G6PD deficiency, a+-thalassemia,
Table 1
Characteristics and health indicators of children aged 6–35 months
in western Kenya, 2010*
Total sample size = 861 n/N %
Sex, female 427/861 49.6
Age, 6–23 months 463/861 53.8
Child slept under bed net previous night 777/837 92.8
Inherited blood disorders
G6PD deficiency 56/829 6.8
Haptoglobin polymorphism, Hp 2-2 164/805 20.4
a+-Thalassemia
Heterozygotes (aa/−a) 319/826 38.6
Homozygotes (−a/−a) 79/826 9.6
Sickle cell hemoglobin
Trait (HbAS) 146/857 17.0
SCA (HbSS) 14/857 1.6
Nutrition status
Anemia (Hb < 11 g/dL) 617/861 71.7
Plasma ferritin < 12 mg/L† 162/850 19.1
Iron deficiency‡ 124/333 37.2
Retinol binding protein < 0.7 mmol/L† 263/850 30.9
Vitamin A deficiency‡ 52/333 15.6
Inflammation
C-reactive protein > 5.0 mg/L 292/850 34.4
a1-acid glycoprotein > 1.0 g/L 518/850 60.9
Any inflammation (AGP > 1.0 g/L or
CRP > 5.0 mg/L)
528/861 61.3
Anthropometry
Stunted (HAZ < −2.0) 255/856 29.8
Underweight (WAZ < −2.0) 104/859 12.1
Wasted (WHZ < −2.0) 30/857 3.5
Nutrition practices
Sprinkles (in last 24 hr) 92/837 11.0
Iron supplementation (in last 24 hr) 58/839 6.3
Tea consumption (in last 24 hr) 692/832 83.2
Breast-feeding (in last 24 hr) 417/838 49.8
Self-reported pica (in last 24 hr) 382/800 47.8
Illness
Clinical malaria 124/857 14.5
Diarrhea (in last 24 hr) 203/836 24.3
Fever (in last 24 hr) 349/829 42.1
Respiratory (in last 24 hr) 319/839 38.0
*G6PD = glucose-6-phosphate dehydrogenase; SCA = sickle cell anemia; Hb = hemoglobin;
HAZ = height-for-age z-score; WAZ = weight-for age z-score; AGP = a1-acud glycoprotein;
CRP = C-reactive protein.
†Uncorrected for inflammation.
‡Excludes N = 517 children with elevated CRP and/or AGP.
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or HbAS/HbSS. In the overall population, 38.6% were a+-
thalassemia heterozygotes, 9.6% a+-thalassemia homozy-
gotes, 20.4% had Hp 2-2, 17.0% had HbAS, 1.6% had HbSS,
and 6.8% had G6PD deficiency; the prevalence of these geno-
types and conditions did not differ significantly by sex (data
not shown).
Anemia prevalence did not differ significantly by Hp sub-
type, HbS genotype, or G6PD deficiency status (Table 2).
However, the prevalence of anemia did differ significantly by
a+-thalassemia strata (overall trend P = 0.003, not shown),
with the prevalence being significantly higher among homozy-
gotes compared with heterozygotes (P = 0.014) or the normal
genotype (P = 0.001). Both heterozygotes and homozygotes
were more likely to have anemia than were those with normal
genotype (crude ORs = 1.53 and 2.31, respectively, not shown).
We found no significant bivariate association between low
ferritin levels and any of the blood disorders investigated. The
prevalence of low RBP was significantly lower among chil-
dren with homozygous a+-thalassemia (P = 0.024) compared
with those with normal genotype; however, the prevalence of
low RBP did not differ significantly between a+-thalassemia
heterozygous children and those with normal genotype (P =
0.600). There was no significant relationship between low
RBP status and any of the other blood disorders. After we
removed children with any inflammation (N = 517; 60.8% of
the study population) from our analyses for VAD and iron
deficiency, iron deficiency was not associated with any disor-
ders and VAD was associated only with the heterozygous a+-
thalassemia genotype (P = 0.034, not shown). Given the high
percentage of children excluded because of inflammation, we
did not conduct a logistic regression analysis of the relation-
ship between VAD (RBP < 0.7 mmol/L and no inflammation)
and a+-thalassemia.
Inflammation was not significantly associated with any
of the inherited blood disorders; elevated CRP varied from
21.4–37.2%, whereas elevated AGP varied from 53.6–64.3%
among the disorders (not shown). None of the inherited blood
disorders were associated with the prevalence of stunting,
wasting, or underweight.
Relationship between homozygous a+-thalassemia (−a/−a)
and low RBP. After adjusting for significant covariates, mul-
tivariate logistic regression results showed no significant rela-
tionship between homozygosity for a+-thalassemia and low
RBP (aOR = 0.61, P = 0.065; 95% CI = 0.36–1.03) but did
show low RBP to be associated with a greater prevalence of
being underweight, having inflammation, and testing positive
for malaria (Table 3). We retained age group in the regression
model to control for any confounding as a result of survival
bias, and we kept HbAS, Hp 2-2 and G6PD deficiency in the
model as potential confounders because of co-inheritance of
blood disorders. We found no evidence of significant colinearity
among the independent variables.
Relationship between a+-thalassemia (−a/aa, −a/−a)
and anemia. After adjusting for significant covariates, a+-
thalassemia was still positively associated with anemia (P =
0.004) (Table 4); children with a+-thalassemia were signifi-
cantly more likely to have anemia than those without (aOR =
1.78; 95% CI = 1.20–2.62). Other variables in the adjusted
model associated with anemia were young age (6–23 months),
low SES, male sex, low ferritin concentration, inflammation,
and a positive malaria smear. Of these, a positive malaria
smear (aOR = 6.81, 95% CI = 4.26–10.89), a low ferritin
concentration (aOR = 4.43, 95% CI = 2.67–7.32), and inflam-
mation (aOR = 3.24, 95% CI = 2.04–5.14) had the strongest
associations with anemia. We kept HbAS, Hp 2-2, and G6PD
deficiency in the model as potential confounders and found
no evidence of significant colinearity among the covariates.
DISCUSSION
Despite a high prevalence of both malnutrition and inherited
blood disorders in this population, we found no significant
Table 2
Nutrition and anthropometry indicators of participant children by blood disorder in western Kenya, 2010*†
Anemia (Hb < 11 g/dL)
N = 861
Ferritin < 12 mg/L‡
N = 850
RBP < 0.7 mmol/L‡
N = 850
Stunted (HAZ < −2), %
N = 856
Underweight (WAZ < −2), %
N = 859
Wasted (WHZ < −2), %
N = 857
G6PD deficiency, N = 829
Normal 551/773 (71.3) 148/766 (19.3) 238/766 (31.1) 228/769 (29.6) 95/771 (12.3) 29/770 (3.8)
Deficient 40/56 (71.4) 9/56 (16.1) 14/56 (25.0) 21/56 (37.5) 8/56 (14.3) 1/56 (1.8)
P value (ref = normal) 0.980 0.546 0.323 0.148 0.670 0.455
Hp polymorphism, N = 858
Hp 1-1 or Hp 2-1 457/641 (71.3) 118/633 (18.6) 187/633 (29.5) 190/638 (29.8) 76/640 (11.9) 23/639 (3.6)
Hp 2-2 122/164 (74.4) 33/164 (20.1) 59/164 (36.0) 49/163 (30.1) 21/163 (12.9) 6/163 (3.7)
P value (ref =Hp 1-1 or
Hp 2-1)
0.411 0.686 0.088 0.940 0.689 0.951
a+-Thalassemia, N = 826
Normal (aa/aa) 286/428 (66.8) 80/427 (18.7) 134/427 (31.4) 131/426 (30.8) 56/428 (13.1) 17/427 (4.0)
Heterozygotes (−a/aa) 241/319 (75.6) 60/313 (19.2) 104/313 (33.2) 93/318 (29.2) 34/319 (10.7) 10/319 (3.1)
P value (ref = aa/aa) 0.014 0.894 0.600 0.677 0.340 0.595
Homozygotes (−a/−a) 65/79 (82.3) 16/78 (20.5) 16/78 (20.5) 22/78 (28.2) 12/77 (15.6) 3/77 (3.9)
P value (ref = aa/aa) 0.001 0.717 0.024 0.668 0.550 0.968
HbS, N = 857
Normal (HbAA) 504/697 (72.3) 127/691 (18.4) 215/691 (31.1) 200/693 (28.9) 81/695 (11.7) 26/694 (3.7)
Trait (HbAS) 101/146 (69.2) 34/144 (23.6) 46/144 (31.9) 52/146 (35.6) 22/146 (15.1) 4/146 (2.7)
P value (ref = HbAA) 0.466 0.154 0.847 0.086 0.169 0.475
SCA (HbSS) 10/14 (71.4) 1/14 (7.14) 1/14 (7.1) 3/14 (21.4) 1/14 (7.14) 0/14 (0)
P value (ref = HbAA) 0.945 0.273 0.056 0.504 0.584 −
*Data presented are numerator/denominator (percentage).
†Hb = Hemoglobin; RBP = retinol binding protein; HAZ = height-for-age z-score; WAZ = weight-for-age z score; WHZ = weight-for-height z-score; G6PD = glucose-6-phosphate
dehydrogenase; Hp = haptoglobin; SCA, sickle cell anemia.
‡Uncorrected for inflammation.
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associations between the blood disorders and conditions
indicative of poor nutrition, except for a positive association
between a+-thalassemia and anemia, which has been found
previously Kenya, Nigeria, and Cambodia population.1,14,38
Thus, our results suggest that a+-thalassemia should be
considered when evaluating anemia etiology and the impact
of anemia interventions. However, there may be limited
value of the other measured blood disorders (G6PD defi-
ciency, Hp 2-2, and HbAS) in interpreting cross-sectional
nutrition surveys.
Although anemia prevalence differed by a+-thalassemia
genotype, the prevalence of low ferritin levels did not. Our
finding is consistent with a previous study among children
on the coast of Kenya.39 It is well known that anemia preva-
lence in children with a+-thalassemia is associated with the
disorder itself or another mechanism associated with the
disorder, rather than with a+-thalassemia’s relationship to
iron metabolism.7,40
The relationship between a+-thalassemia and anemia is
especially important in locations such as western Kenya where
malaria is endemic and the prevalence of a+-thalassemia
(48.2% overall) is high. Awareness of the underlying preva-
lence of blood disorders in a population may help program
officials better interpret the impact of interventions to prevent
and treat anemia. Impact evaluations of anemia prevention
or treatment programs may not be a true reflection of pro-
gram success because anemia attributable to a+-thalassemia
will not be corrected. Though systematic screening for a+-
thalassemia may be unrealistic in regions with limited
resources, partial population sampling or understanding of
the distribution of a+-thalassemia are potential tools that
could be considered during monitoring and evaluation of ane-
mia control programs.
We found a relatively high prevalence of low RBP and
VAD across all blood disorder subgroups.41 We also found
that low RBP status was associated with being underweight,
having a positive malaria smear, and having elevated levels
of inflammatory markers. Clinical trial results have shown
that vitamin A supplementation can decrease the parasite
load,42 but it is unclear if vitamin A supplementation has any
Table 4
Factors associated with anemia among young children aged 6–35 months in western Kenya, 2010* (N = 739)
Variable Unadjusted OR
Adjusted model
OR (95% CI) P
Primary exposure
a+-Thalassemia −a/aa or −a/−a (ref = aa/aa) 1.65† 1.78 (1.20–2.62) 0.004
Child demographics and characteristics
Age 6–23 months (ref = 24–35 months) 1.48† 1.35 (0.91–2.01) 0.140
Breastfeeding in the last 24 hours 1.54† 1.38 (0.94–2.05) 0.103
SES quintile 1–3 (ref = quintile 4–5) 1.44† 1.52 (1.06–2.19) 0.024
Male (ref = female) 1.51† 1.66 (1.06–2.59) 0.026
Underweight (ref =WAZ ³ −2) 2.20† 1.85 (1.02–3.34) 0.043
Morbidity and infection
Low iron (ref = ferritin ³ 12 mg/L) 1.79† 4.43 (2.67–7.32) < 0.001
Inflammation (ref = normal CRP & AGP) 3.43† 3.24 (2.04–5.14) < 0.001
Positive malaria smear (ref = no malaria) 5.79† 6.81 (4.26–10.89) < 0.001
Blood disorders
G6PD deficiency (ref = normal) 1.01 1.01 (0.45–2.31) 0.906
HbAS (ref = HbAA) 0.47 0.69 (0.41–1.16) 0.165
Hp 2-2 (ref = Hp 1-1 or Hp 2-1) 1.23 0.97 (0.63–1.50) 0.905
*SES = socioeconomic status; WAZ = weight-for-age z score; Inflammation = CRP > 5 mg/L and/or AGP > 1 g/L; Normal AGP/CRP = CRP £ 5 mg/L, AGP £ 1 g/L; G6PD = glucose-
6-phosphate-dehydrogenase; HbAS = sickle cell trait; Hp, haptoglobin.
†Unadjusted odds ratio (OR) P < 0.05.
Table 3
Factors associated with low RBP among young children aged 6–35 months in western Kenya, 2010* (N = 756)
Variable Unadjusted OR
Adjusted model
OR (95% CI) P
Primary exposure
a+-Thalassemia: −a/−a (ref = aa/aa or −a/aa) 0.54† 0.61 (0.36–1.03) 0.065
Child demographics and characteristics
Age 6–23 months (ref = 24–35 months) 0.98 1.12 (0.79–1.70) 0.451
Underweight (ref =WAZ ³ −2) 2.30† 1.96 (1.15–3.34) 0.014
Morbidity and infection
Inflammation (ref = normal CRP and AGP) 4.97† 3.33 (2.14–5.18) < 0.001
Positive malaria smear (ref = no malaria) 3.90† 2.72 (1.91–3.87) < 0.001
Blood disorders
G6PD deficiency (ref = normal) 0.74 0.84 (0.41–1.69) 0.615
HbAS (ref = HbAA) 0.86 1.05 (0.66–1.69) 0.829
Hp 2-2 (ref = Hp 1-1 and Hp 2-1) 1.34 1.41 (0.97–2.05) 0.074
*RBP = retinol binding protein; WAZ = weight-for-age z score; Inflammation = CRP > 5 mg/L and/or AGP > 1 g/L; Normal AGP/CRP = CRP £ 5 mg/L, AGP £ 1 g/L; G6PD = glucose-
6-phosphate-dehydrogenase; HbAS = sickle cell trait; Hp, haptoglobin.
†Unadjusted odds ratio (OR) P < 0.05.
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effect on malarial infection in an endemic area such
as Nyando.43
Although our unadjusted results showed an inverse associ-
ation between homozygous a+-thalassemia and low RBP, this
relationship was no longer significant after we controlled for
other variables. However, our fully adjusted results were close
to statistical significance, and our nonsignificant finding may
be a result of the low number of children in our study popula-
tion who had homozygous a+-thalassemia. If homozygosity
for a+-thalassemia and RBP levels is truly associated, studies
of potential mechanisms behind this association and studies
of the relationship between a+-thalassemia and VAD in a
population with a lower prevalence of inflammation may
be warranted.
Our finding that HbAS was not associated with stunting
or anemia was inconsistent with previous findings.44,45
However, there is evidence that biological interactions
among co-inherited hemoglobinopathies46 may have limited
our ability to detect any such reduction in prevalence associ-
ated with HbAS. Additionally, because of low sample sizes,
we were unable to assess nutritional status with HbSS,
which has been shown to be associated with stunting and
micronutrient deficiencies.
Our findings also did not indicate a relationship between
nutritional outcomes and either G6PD deficiency or Hp poly-
morphism, which was unexpected given that both blood dis-
orders have previously been associated with malaria.5,47
Theoretically, people at increased malarial risk from Hp 2-2
and exposure to hemolytic events from G6PD deficiency
would be at higher risk for chronic anemia, with expected
consequences on growth indicators.
It is important to note that in low-resource environments
where the prevalence of disease is high throughout the popu-
lation, any additional disease attributable to inherited blood
disorders may be difficult to detect. In addition, as a cross-
sectional study, survival bias is a potential confounding factor
in the relationship between disease prevalence and either
HbSS or G6PD deficiency. In our study cohort, HbSS chil-
dren were, on average, 8 months younger than those with
other genotypes, suggesting that older HbSS children may
not have survived. Severe symptoms of G6PD deficiency
include neonatal complications such as jaundice, which may
lead to death if not treated. As such, we were not able to
assess the relationship between nutrition and blood disorders
among children with severe forms of these diseases.
In communities with a higher SES distribution and lower
rates of child morbidity and mortality attributable to poor
sanitation and infectious diseases, child survival will likely be
more common. As health outcomes improve in populations
with a high prevalence of inherited blood disorders and more
children reach adulthood, it will be even more important to
understand how inherited blood disorders may be associated
with poor nutrition.
Study strengths and limitations.A strength of this study was
our analysis of data based on the measurement of multiple
nutrition biomarkers and the genotyping of multiple blood
disorders. However, because of the cross-sectional survey
design, any associations between blood disorders and condi-
tions related to malnutrition do not necessarily indicate a
causal relationship. In addition, the use of OR in a cross-
sectional study overstates the prevalence ratio because the
outcomes studied in this analysis are common.
Other study limitations included potential information bias
from self-reported household data, analysis of data from a
relatively small area of Kenya (Nyando Division), which may
not be representative of the country as a whole, and inability
to assess to what magnitude blood disorders change hemato-
logic nutrition indicators. In addition, the survey tool did not
collect data on other potential confounding factors such as
helminth or roundworm parasite infections, vitamin A supple-
mentation, and recent treatment with antimalarial medica-
tion, which limited analyses.
CONCLUSION
Our findings showed that in western Kenya, an area with a
high prevalence of childhood malnutrition, inherited blood
disorders are not associated with most indicators of poor
nutritional status. There may be limited value in assessing
blood disorders for measuring certain nutritional outcomes,
such as growth. The only significant association we found was
between a+thalassemia and anemia. Regional anemia preva-
lence estimates should take this association into consideration
when interpreting anemia etiologies and when recommending
nutritional interventions such as iron supplementation.
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